Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ranibizumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00901186
What this trial is testing

Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaVisual Impairment
Novartis Pharmaceuticals 83
Testing effectiveness (Phase 2)WithdrawnNCT01015495
What this trial is testing

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Who this might be right for
Angioid Streaks
University of Illinois at Chicago
Early research (Phase 1)UnknownNCT01217762
What this trial is testing

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationWet Age-Related Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 62
Post-approval studies (Phase 4)WithdrawnNCT01495208
What this trial is testing

Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment

Who this might be right for
Fibrovascular Pigment Epithelial Detachment
Vitreous -Retina- Macula Consultants of New York
Post-approval studies (Phase 4)Study completedNCT01315275
What this trial is testing

A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema

Who this might be right for
Visual ImpairmentMacular Edema
Novartis Pharmaceuticals 394
Testing effectiveness (Phase 2)Study completedNCT01968239
What this trial is testing

Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT

Who this might be right for
Branch Retinal Vein Occlusion
University of Leipzig 27
Testing effectiveness (Phase 2)Study completedNCT01476449
What this trial is testing

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

Who this might be right for
Diabetic RetinopathyMacular Edema
Retina Vitreous Associates of Florida 20
Post-approval studies (Phase 4)Study completedNCT01448018
What this trial is testing

Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
Centre Hospitalier Intercommunal Creteil 45
Large-scale testing (Phase 3)Study completedNCT00486018
What this trial is testing

The Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 397
Testing effectiveness (Phase 2)Study completedNCT00467935
What this trial is testing

Scotoma Reduction in AMD Patients Treated With Ranibizumab

Who this might be right for
Macular Degeneration
Retina Research Foundation 20
Not applicableStudy completedNCT01330797
What this trial is testing

The Effect of Ranibizumab on Eye Lens Opacity in Cases With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationCataract
Uludag University 13
Large-scale testing (Phase 3)Study completedNCT01377597
What this trial is testing

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 47
Post-approval studies (Phase 4)Study completedNCT02843490
What this trial is testing

Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Johannes Gutenberg University Mainz 71
Testing effectiveness (Phase 2)Study completedNCT00284050
What this trial is testing

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement

Who this might be right for
Diabetic Macular Edema
Novartis 151
Testing effectiveness (Phase 2)Ended earlyNCT01994291
What this trial is testing

A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema

Who this might be right for
Macular Edema, Diabetic
Pfizer 199
Large-scale testing (Phase 3)Looking for participantsNCT07515079
What this trial is testing

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema (DME)
Bio-Thera Solutions 406
Post-approval studies (Phase 4)Study completedNCT02257632
What this trial is testing

Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis Pharmaceuticals 41
Post-approval studies (Phase 4)Study completedNCT03393767
What this trial is testing

Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD

Who this might be right for
Choroidal NeovascularizationAge Related Macular Degeneration
Vista Klinik 30
Large-scale testing (Phase 3)Looking for participantsNCT03683251
What this trial is testing

Extension Study for the Port Delivery System With Ranibizumab (Portal)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Hoffmann-La Roche 1,000
Large-scale testing (Phase 3)Study completedNCT02375971
What this trial is testing

RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity
Novartis Pharmaceuticals 224
Next Page